How to Apply to AbCellera Biologics

13 min read Last updated April 20, 2026 1 open positions

Key Takeaways

  • AbCellera is a Vancouver-headquartered, NASDAQ-listed (ABCL) antibody discovery and therapeutics company with roughly 600 employees, founded in 2012 by CEO Carl Hansen.
  • The company uses Greenhouse as its ATS — applications go through boards.greenhouse.io/abcellera with abcellera.com/careers redirecting into the same board.
  • Hiring in 2026 is concentrated in clinical development, CMC and GMP manufacturing, regulatory affairs, quality, in vivo pharmacology, and toxicology, reflecting the buildout of internal pipeline capabilities.
  • Discovery, computational biology, and AI engineering roles still appear regularly but are more selective and tied to internal program priorities.
  • The 2020 Eli Lilly bamlanivimab royalty stream has wound down to near zero on schedule, and the company is now operating on a multi-year investment thesis funded by its balance sheet, partnership revenue, and a focused wholly-owned pipeline.
  • A late-2024 workforce reduction affected roughly 10 percent of staff, primarily in functions tied to legacy partnership volume; the company has been publicly transparent about the rationale.
  • Interview loops are scientifically rigorous and typically include a 30 to 45 minute presentation followed by a cross-functional Q and A panel and several one-on-one rounds.
  • Vancouver-based work is the default; the company sponsors Canadian work permits for the right candidates but expects relocation for nearly all roles.
  • Compensation is competitive for Canadian biotech, paid in Canadian dollars, and includes meaningful but more modest equity than U.S. peers.
  • Resumes should be precise about platforms, assays, regulatory frameworks, and computational stacks; vague or generic descriptions consistently underperform.

About AbCellera Biologics

AbCellera Biologics Inc. is a Canadian biotechnology company headquartered in Vancouver, British Columbia, that combines high-throughput microfluidics, machine learning, and computational biology to discover and develop therapeutic antibodies. Founded in 2012 as a spinout from the University of British Columbia by CEO Carl Hansen, AbCellera went public on NASDAQ in December 2020 under the ticker ABCL in one of the largest biotech IPOs in Canadian history, raising roughly US$556 million. The company employs approximately 600 people, the vast majority of whom are based at its expanding Vancouver campus on West 6th Avenue, with smaller satellite footprints supporting business development and partnerships. AbCellera built its early reputation as a partnership-driven discovery engine. The company's core platform pairs single-cell microfluidic screening of millions of B cells with proprietary AI models that mine antibody sequence and structure data, allowing it to identify rare therapeutic candidates in days rather than months. That capability put AbCellera on the global map in early 2020, when its scientists isolated the antibody that became Eli Lilly's bamlanivimab, one of the first authorized COVID-19 monoclonal antibody therapeutics. Royalties from that program produced a multi-year revenue windfall that funded AbCellera's transition from a service-style discovery partner into a fully integrated therapeutics company. By 2025, those royalties had wound down to near zero, an entirely expected trajectory but one that has reshaped how the company talks about its business and how it hires. Today, AbCellera operates roughly 50 active discovery and development partnerships with pharma and biotech sponsors, ranging from large multinationals to early-stage virtual companies. Partnership revenue, milestones, and downstream royalties remain a meaningful part of the model, but the strategic center of gravity has shifted decisively toward AbCellera's own wholly-owned therapeutic pipeline. The company has filed multiple INDs for in-house programs, with the first wave concentrated in oncology, endocrinology, and autoimmune indications, and is building the GMP manufacturing, clinical operations, and regulatory infrastructure required to take molecules from discovery through proof-of-concept clinical trials in-house. Two purpose-built Vancouver facilities — a CMC and GMP manufacturing site and a translational and clinical operations hub — are the visible evidence of that pivot, and most of the company's open requisitions in 2026 reflect the staffing needs of those facilities. For candidates, the practical implication is that AbCellera is no longer hiring primarily for discovery throughput. Demand has shifted toward clinical development, CMC, regulatory affairs, quality assurance and quality control, in vivo pharmacology, toxicology, and the engineering, automation, and bioinformatics roles that support an integrated drug developer. Discovery and platform roles still appear, but they are now more selective and more closely tied to internal pipeline priorities. The company also continues to recruit aggressively for student co-ops through UBC, SFU, BCIT, and University of Waterloo programs, which remain a significant talent feeder. AbCellera underwent a workforce reduction in late 2024 that affected roughly 10 percent of staff, primarily in functions tied to legacy partnership volume and overlapping discovery operations. Leadership has been transparent that the company is balancing a multi-year investment in clinical infrastructure against a finite cash runway, and that hiring is now disciplined and prioritized around milestones for the wholly-owned pipeline. Candidates should treat that context as honest signal rather than a red flag: the company has substantial cash on its balance sheet, a real platform advantage, and a credible path to clinical readouts, but it is no longer the open-ended growth story it appeared to be in 2021.

Application Process

  1. 1
    Browse open roles at boards

    Browse open roles at boards.greenhouse.io/abcellera or via the careers page at abcellera.com/careers, which redirects into the same Greenhouse-hosted board. All postings are based in Vancouver, British Columbia, with a small number of remote-eligible exceptions usually called out in the job title or first paragraph.

  2. 2
    Read the job description carefully and map your background to the responsibiliti

    Read the job description carefully and map your background to the responsibilities and required qualifications sections. AbCellera writes detailed, specific postings — they list the exact assays, instruments, software stacks, regulatory frameworks, or therapeutic areas they expect, and your resume should mirror that vocabulary where it is honestly applicable.

  3. 3
    Apply directly through the Greenhouse application form

    Apply directly through the Greenhouse application form. You will upload a resume (PDF strongly preferred), optionally a cover letter, and complete a short set of structured questions covering work authorization in Canada, willingness to relocate to Vancouver, and self-identification fields used for diversity reporting. There is no separate account to create, but Greenhouse will email you a confirmation and any future status updates.

  4. 4
    Expect an initial response window of two to four weeks for most roles

    Expect an initial response window of two to four weeks for most roles. Recruiters at AbCellera generally screen actively rather than letting applications sit, but volume on senior clinical and CMC roles can stretch the timeline. If you have not heard back after four weeks, a polite follow-up via LinkedIn to the named recruiter or hiring manager is acceptable and not held against you.

  5. 5
    If your background passes the initial screen, a Talent Acquisition partner will

    If your background passes the initial screen, a Talent Acquisition partner will schedule a 30 to 45 minute phone or video introductory call. This call covers your motivation for joining AbCellera, a high-level walkthrough of your most relevant experience, compensation expectations in Canadian dollars, and your work authorization status. It is conversational, not technical.

  6. 6
    Successful candidates then move into a hiring-manager interview, typically 45 to

    Successful candidates then move into a hiring-manager interview, typically 45 to 60 minutes by video, focused on the technical and scientific depth of the role. For research and engineering roles this is where you should expect probing questions about your day-to-day craft, your decision-making on prior projects, and your familiarity with the specific platforms and methods listed in the job description.

  7. 7
    Most scientific and senior individual contributor roles include a presentation r

    Most scientific and senior individual contributor roles include a presentation round, where you are asked to deliver a 30 to 45 minute talk on a research project or program of work you led, followed by Q and A from a cross-functional panel of three to six AbCellera scientists and engineers. Panels are technically rigorous and will challenge methodology, statistical interpretation, and your articulation of trade-offs.

  8. 8
    Following the presentation, candidates typically meet with two to four additiona

    Following the presentation, candidates typically meet with two to four additional interviewers in 30 to 45 minute one-on-one sessions covering team fit, cross-functional collaboration, and leadership or mentorship style for senior roles. These can occur on the same day as the presentation for an on-site loop or be spread across multiple video sessions over one to two weeks.

  9. 9
    References are usually requested late in the process, often after the on-site lo

    References are usually requested late in the process, often after the on-site loop and before an offer is extended. AbCellera typically asks for two to three professional references and will contact them directly by phone or video. Plan accordingly and give your references advance notice.

  10. 10
    Offers are extended verbally by the recruiter, followed by a written offer packa

    Offers are extended verbally by the recruiter, followed by a written offer package within one to three business days. Compensation is paid in Canadian dollars and typically includes base salary, an annual cash bonus target, restricted stock units that vest over four years, comprehensive Canadian extended health benefits, an employee stock purchase plan, and a relocation allowance for candidates moving to Vancouver. Equity grants for individual contributors are meaningful but more modest than U.S. biotech peers.

  11. 11
    Background checks, reference verification, and finalization of immigration paper

    Background checks, reference verification, and finalization of immigration paperwork (if applicable) close out the process. For international hires AbCellera regularly sponsors Canadian work permits and supports the permanent residency pathway, but timelines vary materially by country of origin and current Canadian immigration backlogs.


Resume Tips for AbCellera Biologics

recommended

Lead with the specific platforms, instruments, and assays you have hands-on expe

Lead with the specific platforms, instruments, and assays you have hands-on experience with. AbCellera's recruiters and hiring managers scan for concrete capability — single-cell screening platforms, flow cytometry instruments, mass spec setups, BLI and SPR for binding kinetics, specific cell culture systems, GMP-relevant equipment — not general descriptors like ‘molecular biology techniques.'

recommended

For computational and engineering roles, name your stack precisely

For computational and engineering roles, name your stack precisely. Python, PyTorch, JAX, scikit-learn, RDKit, structural biology tools like AlphaFold or Rosetta, workflow systems like Nextflow or Snakemake, and cloud platforms like AWS or GCP should appear by name where you have used them in production or research contexts. Vague phrasing like ‘machine learning' will be discounted.

recommended

If you have wet-lab and dry-lab integration experience, emphasize it

If you have wet-lab and dry-lab integration experience, emphasize it. AbCellera's competitive advantage is computational design and AI tightly coupled to high-throughput experimentation. Candidates who can speak fluently across both sides of that boundary are unusually valuable, and your resume should make any such experience easy to find.

recommended

For clinical, CMC, regulatory, and quality roles, be explicit about the regulato

For clinical, CMC, regulatory, and quality roles, be explicit about the regulatory frameworks and product modalities you have worked under. ICH guidelines, Health Canada and FDA submission types (IND, CTA, BLA), GMP and GLP environments, QMS platforms, and specific therapeutic areas all matter. If you have biologics-specific experience (as opposed to small molecule), call it out.

recommended

Quantify outcomes in scientifically meaningful ways

Quantify outcomes in scientifically meaningful ways. ‘Improved assay throughput from 96 to 1,536 wells per day' or ‘Led IND-enabling toxicology package for first-in-human submission accepted by FDA in Q3 2024' is far more useful than ‘drove improvements' or ‘managed studies.' Numbers, regulatory milestones, publications, and patents all signal real ownership.

recommended

List publications, preprints, and patents on a separate, clearly labeled section

List publications, preprints, and patents on a separate, clearly labeled section, with full citation and DOI or patent number. AbCellera is a publication-active organization and reviewers will look for first-author papers, preprints on bioRxiv, and inventorship on relevant patents as primary signals of scientific seriousness.

recommended

Keep the resume to two pages for individual contributor roles and a maximum of t

Keep the resume to two pages for individual contributor roles and a maximum of three pages for senior or director-level roles. AbCellera's reviewers prefer dense, well-organized resumes over multi-page narrative CVs. An academic-style CV is acceptable for principal scientist and above but should still be carefully edited.

recommended

Submit as a PDF with a simple, ATS-friendly layout

Submit as a PDF with a simple, ATS-friendly layout. Single-column structure, standard fonts (Arial, Calibri, or similar), no embedded graphics or text boxes, and consistent date formatting. Greenhouse parses PDFs reliably when the underlying layout is simple, and a clean parse means your skills surface accurately in keyword searches.

recommended

Include your work authorization status near the top of the resume or in your cov

Include your work authorization status near the top of the resume or in your cover letter. AbCellera regularly sponsors Canadian work permits but knowing your status up front helps the recruiter route you correctly. ‘Canadian citizen,' ‘Canadian permanent resident,' ‘open work permit valid through [date],' or ‘requires Canadian work permit sponsorship' are all acceptable phrasings.

recommended

Customize the top third of your resume to the specific role

Customize the top third of your resume to the specific role. The first half-page is where most reviewers form their first impression — a short summary or relevant-experience block aligned to the posting's key responsibilities will dramatically increase your odds of advancing past the initial screen.



Interview Culture

AbCellera's interview culture is recognizably modern Canadian biotech: scientifically rigorous, conversational rather than adversarial, and structured to evaluate both technical depth and the ability to work across disciplinary boundaries. The company hires from a deep Vancouver and broader Canadian academic ecosystem — UBC, SFU, McGill, Toronto, Waterloo, and the major hospital research institutes — and many interviewers have backgrounds in academic research, which shapes the tone toward genuine scientific curiosity. Expect questions to probe how you think, not just what you have done. The scientific presentation is the centerpiece of most interview loops for research, engineering, and senior individual contributor roles. Candidates are typically asked to give a 30 to 45 minute talk on a project they led, followed by an extended Q and A. The panel will include three to six interviewers spanning the immediate hiring team and adjacent functions — for example, a discovery scientist candidate might present to a panel that includes a computational biologist, a bioinformatician, a CMC representative, and a senior leader from translational research. Questions tend to focus on experimental design choices, statistical handling, the boundaries of what your data actually supports, and how you would design the next set of experiments. Defensiveness reads poorly; intellectual honesty about limitations reads very well. One-on-one interviews are spread across team members the candidate would work with directly and a small number of cross-functional partners. Expect a mix of behavioral questions (collaboration, conflict resolution, mentorship, prioritization under uncertainty), technical deep dives in areas not covered by the presentation, and culture and motivation questions. AbCellera explicitly screens for what it describes as ‘high-agency' people who are comfortable operating in ambiguity and pushing decisions forward without waiting for permission, a pattern common in companies transitioning from a startup to a clinical-stage operating model. For clinical, CMC, regulatory, and quality roles, the presentation is sometimes replaced or supplemented by a structured case discussion: the candidate is asked to walk through how they would approach a specific regulatory submission, technology transfer, or quality system question. The intent is to evaluate domain depth and decision-making frameworks, not to test trivia. Senior leaders are also evaluated on their ability to articulate a credible plan for the first 90 days and the first year in the role. The company's stated values — transparency, scientific integrity, and a bias toward action — show up consistently in how interviews are conducted. Candidates frequently report that interviewers are unusually open about the company's strategic situation, including the COVID royalty wind-down and the pipeline pivot, and welcome the same candor in return. Compensation discussions are direct and grounded in published Vancouver biotech ranges. Feedback loops between rounds are reasonably fast for a company of AbCellera's size, with most candidates hearing back within three to seven business days after each stage. The overall process from first contact to offer typically runs four to eight weeks.

What AbCellera Biologics Looks For

  • Deep technical or scientific craft. AbCellera consistently hires for genuine depth in a defined area — protein engineering, single-cell methods, structural biology, machine learning for biology, GMP manufacturing, clinical pharmacology — over generalist breadth. Candidates who can demonstrate that they have built something difficult and understand it deeply tend to advance.
  • Comfort at the wet-lab and computational interface. Even in nominally pure wet-lab or pure computational roles, AbCellera prefers candidates who can have a substantive conversation across that boundary. The company's competitive advantage is the integration of high-throughput experimentation and AI-driven design, and that integration only works when individual contributors can collaborate fluently across disciplines.
  • High agency and ownership. Interviewers actively probe for evidence that candidates have driven projects forward in ambiguous, resource-constrained environments. ‘I noticed X was broken and rebuilt it,' ‘I owned this submission end-to-end,' or ‘I made the call to kill the program after seeing the data' are the kinds of statements that resonate. Passive descriptions of contributions tend to underperform.
  • Willingness to base in Vancouver. The vast majority of AbCellera roles are on-site or hybrid in Vancouver. The company is candid about this and prefers candidates who have either lived in Vancouver or are clearly motivated to relocate. Strong candidates who treat the location as a deal-breaker negotiable late in the process tend to stall.
  • Track record of shipping in regulated environments, for relevant roles. For CMC, clinical, regulatory, and quality positions, AbCellera screens hard for candidates who have actually delivered submissions, supported audits, or run GMP systems — not just observed them. Specific experience with biologics (rather than small molecule only) is a meaningful plus.
  • Scientific communication ability. Both written (publications, regulatory documents, internal memos) and oral (presentations, cross-functional defenses) communication are evaluated explicitly. Candidates who can take a complex technical topic and explain it cleanly to a mixed-discipline audience consistently outperform candidates who cannot, regardless of underlying technical depth.
  • Cultural fit with a maturing organization. AbCellera is no longer a small startup, and it is also not a large pharma. Interviewers look for candidates who can operate well in that middle zone — comfortable with structure where it exists, willing to build it where it does not, and able to flex between formal process and improvisation as the situation requires.
  • Long-term motivation aligned with the company's pipeline strategy. Candidates who frame their interest primarily around platform technology, partnership revenue, or COVID-era achievements often read as out of date. Candidates who can articulate why they want to help take a wholly-owned program from discovery through proof-of-concept clinical readouts tend to land much better.

Frequently Asked Questions

What ATS does AbCellera use to manage applications?
AbCellera uses Greenhouse, hosted at boards.greenhouse.io/abcellera and the newer job-boards.greenhouse.io/abcellera URL. The careers link at abcellera.com/careers redirects directly into the Greenhouse-hosted board. Greenhouse parses PDF resumes reliably as long as the layout is single-column and free of text boxes or embedded images.
Is AbCellera still hiring after the 2024 layoffs?
Yes. AbCellera reduced its workforce by approximately 10 percent in late 2024 to align headcount with a more focused internal pipeline strategy, but the company continues to hire actively in 2026. Open roles are concentrated in clinical development, CMC, regulatory affairs, GMP manufacturing, quality, and translational research, reflecting the buildout of integrated drug-development capabilities rather than discovery throughput.
Are AbCellera roles based in Vancouver, or is remote work available?
The vast majority of AbCellera roles are on-site or hybrid at the company's Vancouver, British Columbia campus. A small number of roles in business development or specialized functions can be remote-eligible, but those exceptions are usually called out in the job title or the first paragraph of the posting. Candidates not based in Vancouver should plan for relocation; AbCellera offers a relocation allowance and supports work permit sponsorship where required.
Does AbCellera sponsor work permits for international candidates?
Yes, AbCellera regularly sponsors Canadian work permits for international hires, particularly for senior scientific, engineering, and clinical roles where the talent pool is global. The company also supports the permanent residency pathway for employees who choose to settle in Canada. Sponsorship timelines depend on country of origin and current Canadian immigration processing backlogs, so plan for a longer overall timeline if sponsorship is required.
What does the AbCellera interview process look like end-to-end?
A typical loop runs four to eight weeks and includes a recruiter screen, a hiring-manager interview, a 30 to 45 minute scientific or technical presentation followed by a cross-functional Q and A panel, two to four one-on-one team interviews, and reference checks. Clinical, CMC, regulatory, and quality roles sometimes substitute a structured case discussion for the formal presentation. Compensation conversations happen early and are direct, and offers are extended verbally followed by a written package within a few business days.
How important is publication and patent history for AbCellera scientific roles?
Publications, preprints, and patents are meaningful signals for scientific roles, particularly at the principal scientist level and above. AbCellera is a publication-active organization with an academically connected leadership team, and reviewers will look at first-author papers, bioRxiv preprints, and inventorship on relevant patents as primary indicators of scientific seriousness. Industry candidates without an extensive publication record are not penalized as long as their applied work is well-documented through case studies, regulatory submissions, or product launches.
What is the compensation structure at AbCellera?
Compensation is paid in Canadian dollars and typically includes base salary, an annual cash bonus targeted to a percentage of base, restricted stock units that vest over four years on a standard cliff-and-monthly schedule, comprehensive extended health benefits through a Canadian carrier, an employee stock purchase plan, and a relocation allowance for candidates moving to Vancouver. Equity grants for individual contributors are meaningful but more modest than U.S. biotech peers, reflecting the lower market norms in Canadian biotech.
Should I mention the bamlanivimab program in my interviews?
Only if you have a specific and substantive connection to the work. The bamlanivimab program was a defining achievement for AbCellera in 2020, but the COVID royalty stream has wound down and the company has clearly moved on strategically. Candidates who frame their motivation primarily around the bamlanivimab story can read as out of date. A better framing is to acknowledge the platform capability that enabled the program, then connect your interest to the wholly-owned pipeline AbCellera is building today.
How should I prepare my scientific presentation?
Pick a project you led where you can speak in depth about experimental design, the data, the limitations, and the decisions you made along the way. Plan for 30 to 45 minutes of content with substantial Q and A. Lean into the uncertainty in your data — interviewers will probe for intellectual honesty, and candidates who acknowledge what their data does not support consistently outperform candidates who oversell. If your work is confidential, prepare a version that conveys the scientific substance without exposing proprietary information; AbCellera is familiar with that constraint.
Does AbCellera hire students and interns?
Yes. AbCellera runs a substantial co-op and internship program, primarily with UBC, SFU, BCIT, the University of Waterloo, and other major Canadian universities. Co-op terms are typically eight months, span discovery, engineering, manufacturing, quality, and finance functions, and are posted through Greenhouse alongside full-time roles. The co-op program is a meaningful feeder into full-time hiring and is worth pursuing seriously if you are an eligible student.
What is the company's current strategic focus for candidates to understand?
AbCellera is in the middle of a multi-year transition from a discovery-and-partnership engine to a fully integrated antibody therapeutics company. The visible elements of that transition are the GMP manufacturing facility, the translational and clinical operations buildout, the growing wholly-owned pipeline (with early programs in oncology, endocrinology, and autoimmune indications), and the disciplined hiring posture announced after the late-2024 workforce reduction. Candidates who understand and align with that direction are significantly more likely to land well in interviews.

Open Positions

AbCellera Biologics currently has 1 open positions.

Check Your Resume Before Applying → View 1 open positions at AbCellera Biologics

Related Resources

Related Articles


Sources

  1. AbCellera Careers (Greenhouse Job Board)
  2. AbCellera Greenhouse Jobs API
  3. AbCellera Biologics Inc. — Official Careers Page
  4. AbCellera Biologics Inc. — Company Overview
  5. AbCellera Biologics Inc. (NASDAQ: ABCL) — Investor Relations
  6. AbCellera Biologics Inc. — SEC Filings (Form 10-K and 10-Q)
  7. Eli Lilly bamlanivimab — FDA Emergency Use Authorization (Originating Discovery: AbCellera)